CoChat

Therapeutic Potential of Secreted Amyloid Precursor Protein APPsα

Open access
Mockett, Bruce G., Richter, Max, Abraham, Wickliffe C., Müller, Ulrike C. · 2017 · Frontiers in Molecular Neuroscience
Cited by 115

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Cleavage of the amyloid precursor protein by α-secretase generates an extracellularly released fragment termed secreted amyloid precursor protein-alpha (APPsα). Not only is this process of interest due to the cleavage of APP within the amyloid-beta sequence, but APPsα itself has many physiological properties that suggest its great potential as a therapeutic target. For example, APPsα is neurotrophic, neuroprotective, neurogenic, a stimulator of protein synthesis and gene expression, and enhances long-term potentiation and memory. While most early studies have been conducted in vitro, effectiveness in animal models is now being confirmed. These studies have revealed that either upregulating α-secretase activity, acutely administering APPsα or chronic delivery of APPsα via a gene therapy approach can effectively treat mouse models of Alzheimer’s disease and other disorders such as traumatic head injury. Together these findings suggest the need for intensifying research efforts to harness the therapeutic potential of this multifunctional protein.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnmol.2017.00030

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Cited by

See all 115

Metadata

Authors
Mockett, B. G., Richter, M., Abraham, W. C., & Müller, U. C.
Venue
Frontiers in Molecular Neuroscience
Published
2017-02-07
Volume
10
Pages
30-30
ISSN
1662-5099 (ISSN-L)
OpenAlex
W2587355471
Cited by
115
References
38
FWCI
7.04
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Therapeutic Potential of Secreted Amyloid Precursor Protein APPsα. https://app.cochat.ai/papers/10.3389/fnmol.2017.00030
The paper
Mockett, B. G., Richter, M., Abraham, W. C., & Müller, U. C. (2017). Therapeutic Potential of Secreted Amyloid Precursor Protein APPsα. Frontiers in Molecular Neuroscience. https://doi.org/10.3389/fnmol.2017.00030

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.